• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管高级别异型增生光动力治疗后狭窄形成的预测因素

Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.

作者信息

Prasad Ganapathy A, Wang Kenneth K, Buttar Navtej S, Wongkeesong Louis-Michel, Lutzke Lori S, Borkenhagen Lynn S

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

出版信息

Gastrointest Endosc. 2007 Jan;65(1):60-6. doi: 10.1016/j.gie.2006.04.028.

DOI:10.1016/j.gie.2006.04.028
PMID:17185080
Abstract

BACKGROUND

Stricture formation is the leading cause of long-term morbidity after photodynamic therapy (PDT). Risk factors for stricture formation have not been studied.

OBJECTIVE

To assess risk factors for stricture formation in patients undergoing PDT for Barrett's esophagus with high-grade dysplasia (HGD).

DESIGN

Retrospective cohort study.

SETTING

Barrett's Unit, Mayo Clinic, Rochester, Minnesota.

METHODS

Records of patients undergoing PDT for HGD were reviewed. Patients underwent PDT by using either bare cylindrical diffusing fibers (2.5-5.0 cm in length) or balloon diffusers with 5- to 7-cm windows. Univariate and multivariate logistic regression analyses were performed to assess risk factors for stricture formation.

MAIN OUTCOME MEASUREMENT

Esophageal stricture formation.

RESULTS

Thirty-five of 131 patients (27%) developed strictures. On multivariate analysis, statistically significant predictors of stricture formation were the following: EMR before PDT was odds ratio (OR) 2.7, 95% confidence interval (CI) 1.13-6.59; a prior history of esophageal stricture was OR 2.7, 95% CI 1.15-6.47; and the number of PDT applications was OR 2.2, 95% CI 1.22-4.12. The OR for stricture formation in patients when centering balloons were used was 0.41, 95% CI 0.11-1.46, P = .168, indicating that centering balloons did not significantly decrease the risk of stricture formation.

LIMITATIONS

Retrospective single-center study; small proportion of patients treated with centering balloons.

CONCLUSIONS

Risk factors for development of strictures after PDT included history of a prior esophageal stricture, performance of EMR before PDT, and more than 1 PDT application in 1 treatment session. The use of centering balloons was not associated with a statistically significant reduction in the risk of stricture formation.

摘要

背景

狭窄形成是光动力疗法(PDT)后长期发病的主要原因。狭窄形成的危险因素尚未得到研究。

目的

评估接受PDT治疗的高级别异型增生(HGD)巴雷特食管患者狭窄形成的危险因素。

设计

回顾性队列研究。

地点

明尼苏达州罗切斯特市梅奥诊所巴雷特病科。

方法

回顾接受PDT治疗HGD患者的记录。患者使用裸露的圆柱形扩散光纤(长度为2.5 - 5.0厘米)或带有5至7厘米窗口的球囊扩散器进行PDT。进行单因素和多因素逻辑回归分析以评估狭窄形成的危险因素。

主要观察指标

食管狭窄形成。

结果

131例患者中有35例(27%)发生狭窄。多因素分析显示,狭窄形成的统计学显著预测因素如下:PDT前进行内镜下黏膜切除术(EMR)的比值比(OR)为2.7,95%置信区间(CI)为1.13 - 6.59;既往有食管狭窄病史的OR为2.7,95% CI为1.15 - 6.47;PDT应用次数的OR为2.2,95% CI为1.22 - 4.12。使用定心球囊的患者狭窄形成的OR为0.41,95% CI为0.11 - 1.46,P = 0.168,表明定心球囊并未显著降低狭窄形成的风险。

局限性

回顾性单中心研究;使用定心球囊治疗的患者比例较小。

结论

PDT后狭窄形成的危险因素包括既往食管狭窄病史、PDT前进行EMR以及在1个治疗疗程中进行超过1次PDT应用。使用定心球囊与狭窄形成风险的统计学显著降低无关。

相似文献

1
Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.巴雷特食管高级别异型增生光动力治疗后狭窄形成的预测因素
Gastrointest Endosc. 2007 Jan;65(1):60-6. doi: 10.1016/j.gie.2006.04.028.
2
Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.光动力疗法(PDT)用于治疗伴有发育异常或早期癌症的巴雷特食管。
Eur J Cardiothorac Surg. 2006 Jan;29(1):30-4. doi: 10.1016/j.ejcts.2005.10.033. Epub 2005 Dec 6.
3
Patient predictors of esophageal stricture development after photodynamic therapy.光动力治疗后食管狭窄发生的患者预测因素。
Clin Gastroenterol Hepatol. 2008 Mar;6(3):302-8. doi: 10.1016/j.cgh.2007.12.001. Epub 2008 Feb 6.
4
Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.巴雷特发育异常或癌症患者接受光动力治疗的临床经验。
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1125-31. doi: 10.1111/j.1365-2036.2004.02209.x.
5
Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.卟吩姆钠光动力疗法用于治疗高级别异型增生的巴雷特食管。
Lasers Surg Med. 2006 Jun;38(5):390-5. doi: 10.1002/lsm.20367.
6
Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.内镜黏膜切除术联合光动力疗法与食管切除术治疗Barrett食管早期腺癌的比较
Clin Gastroenterol Hepatol. 2003 Jul;1(4):252-7.
7
Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.局部应用δ-氨基乙酰丙酸用于巴雷特食管的光动力治疗是否足够?一项初步研究。
Endoscopy. 2002 Aug;34(8):611-6. doi: 10.1055/s-2002-33247.
8
Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.接受放化疗后再行光动力治疗的不可手术切除的表浅食管癌患者比直接接受光动力治疗的患者并发症更严重。
Am J Gastroenterol. 2008 Sep;103(9):2215-9. doi: 10.1111/j.1572-0241.2008.02042.x.
9
Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.光动力疗法(PDT)作为巴雷特食管高级别异型增生消融治疗的长期疗效。
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):561-5. doi: 10.1016/j.pdpdt.2013.06.002. Epub 2013 Sep 17.
10
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.使用卟吩姆钠进行光动力疗法治疗巴雷特食管高级别异型增生:国际、部分盲法、随机 III 期试验
Gastrointest Endosc. 2005 Oct;62(4):488-98. doi: 10.1016/j.gie.2005.06.047.

引用本文的文献

1
Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer.注射用替莫泊芬用于食管癌的光动力治疗临床实践
J Clin Med. 2021 Jun 24;10(13):2785. doi: 10.3390/jcm10132785.
2
Current endoscopic methods of radical therapy in early esophageal cancer.早期食管癌根治性治疗的当前内镜方法。
J Med Life. 2015 Apr-Jun;8(2):150-6.
3
Low grade dysplasia in Barrett's esophagus: Should we worry?巴雷特食管的低度发育异常:我们应该担心吗?
World J Gastrointest Pathophysiol. 2014 May 15;5(2):91-9. doi: 10.4291/wjgp.v5.i2.91.
4
Predictors of esophageal stricture formation post endoscopic mucosal resection.内镜黏膜切除术后食管狭窄形成的预测因素
Clin Endosc. 2014 Mar;47(2):155-61. doi: 10.5946/ce.2014.47.2.155. Epub 2014 Mar 31.
5
When is pre-emptive treatment necessary after endoscopic mucosal resection of early esophageal neoplasm?早期食管肿瘤内镜黏膜切除术后何时需要进行预防性治疗?
Clin Endosc. 2014 Mar;47(2):124-6. doi: 10.5946/ce.2014.47.2.124. Epub 2014 Mar 31.
6
Barrett's esophagus: review of diagnosis and treatment.巴雷特食管:诊断与治疗综述。
Gastroenterol Rep (Oxf). 2013 Jul;1(1):9-18. doi: 10.1093/gastro/got015. Epub 2013 Apr 30.
7
Role of Photodynamic Therapy for the Upper Gut.光动力疗法在上消化道的作用。
Tech Gastrointest Endosc. 2010 Jan;12(1). doi: 10.1016/j.tgie.2010.01.009.
8
Safety of endoscopic mucosal resection for Barrett's esophagus.内镜黏膜切除术治疗 Barrett 食管的安全性。
Am J Gastroenterol. 2013 Sep;108(9):1440-7; quiz 1448. doi: 10.1038/ajg.2013.187. Epub 2013 Jul 16.
9
Ablation is in the eye of the beholder.旁观者清。
Clin Gastroenterol Hepatol. 2013 Jun;11(6):643-4. doi: 10.1016/j.cgh.2013.02.028. Epub 2013 Mar 21.
10
Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.内镜下 Barrett 食管的处理:内镜技术的进展。
Dig Dis Sci. 2012 Dec;57(12):3055-64. doi: 10.1007/s10620-012-2279-0. Epub 2012 Jul 4.